−0.730 SEK
−16.40 M SEK
0.00 SEK
14.91 M
About ELICERA THERAPEUTICS AB
Sector
Industry
CEO
Jamal El-Mosleh
Website
Headquarters
Gothenburg
Founded
2014
ISIN
SE0015382080
FIGI
BBG01161YY50
Elicera Therapeutics AB operates as a clinical stage immuno-oncology company, which engages in the development of cell and gene therapies for immune-based cancer treatments. Its drug candidates are in the field of oncolytic viruses and in the field of cell therapies, in addition to a platform technology called iTANK (ImmunoTherapies Activated with Nap for efficient Killing) for further immune enhancement of treatments in said fields. Its product pipeline includes ELC-100, ELC-201, ELC-301, and ELC-401. The company was founded by Jamal El-Mosleh, Di Yu, and Magnus Essand in 2014 and is headquartered in Gothenburg, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ELIC is 1.670 SEK — it has decreased by −4.57% in the past 24 hours. Watch ELICERA THERAPEUTICS AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ELICERA THERAPEUTICS AB stocks are traded under the ticker ELIC.
ELIC stock has fallen by −5.38% compared to the previous week, the month change is a 0.60% rise, over the last year ELICERA THERAPEUTICS AB has showed a −65.28% decrease.
We've gathered analysts' opinions on ELICERA THERAPEUTICS AB future price: according to them, ELIC price has a max estimate of 2.50 SEK and a min estimate of 2.50 SEK. Watch ELIC chart and read a more detailed ELICERA THERAPEUTICS AB stock forecast: see what analysts think of ELICERA THERAPEUTICS AB and suggest that you do with its stocks.
ELIC reached its all-time high on Aug 3, 2021 with the price of 9.000 SEK, and its all-time low was 0.850 SEK and was reached on May 15, 2024. View more price dynamics on ELIC chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ELIC stock is 6.59% volatile and has beta coefficient of −0.36. Track ELICERA THERAPEUTICS AB stock price on the chart and check out the list of the most volatile stocks — is ELICERA THERAPEUTICS AB there?
Today ELICERA THERAPEUTICS AB has the market capitalization of 58.61 M, it has increased by 0.29% over the last week.
Yes, you can track ELICERA THERAPEUTICS AB financials in yearly and quarterly reports right on TradingView.
ELIC net income for the last quarter is −2.51 M SEK, while the quarter before that showed −5.62 M SEK of net income which accounts for 55.28% change. Track more ELICERA THERAPEUTICS AB financial stats to get the full picture.
No, ELIC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 31, 2024, the company has 2.00 employees. See our rating of the largest employees — is ELICERA THERAPEUTICS AB on this list?
Like other stocks, ELIC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ELICERA THERAPEUTICS AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ELICERA THERAPEUTICS AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ELICERA THERAPEUTICS AB stock shows the sell signal. See more of ELICERA THERAPEUTICS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.